News About: Pharm. Industry
Bio-equivalent drugs helps NHI finance saving.
An increased number of drugs proven of its bio-equivalency to the original drugs and due extended scope of physician's prescriptions have greatly contributed to save the National Health Insurance (NHI) fund
The ph...
Korea's OTC output showing sluggish trends for last decade
The Korea Pharmaceutical Manufacturers Association says that it recently analyzed OTC output trends for the past 10 years and found that:
- Despite the sustained growth of pharmaceutical production for the past 10 ...
MOIE to support BIT fusion technologies.
The Ministry of Industry and Energy announced a 5 year investment plan at about 69,500 million won for a BIT industry, a combined of BT (Bio technology) and IT (Information technology) industry to build up a national ...
Dietary supplement with anticancer properties to be launched in Korea
SVN Company, a local firm which was set up by the investment of Samjung ITC Group, said it would exclusively launch Selected Vegetables, a dietary supplement containing molecules that have anticancer or immune system-...
Registration for slightly modified drugs on cross road.
Even during the drug registration review for any original new drug, the industry claimed that the health registration for a slightly modified new drug, for instance, developing a new salt derivative from the original ...
Boryung markets lung cancer diagnostic reagent MAZE kit
Boryung Pharm said it has signed an agreement with Daeyong to distribute MAGE (melanoma antigen gene) kit, a patented lung cancer diagnostic reagent, to hospitals in Seoul and Kyunngi Province. The kit's test method w...
Bayer/GSK bravely to bet Levitra in impotence market.
In the first year anniversary event of launching Levitra, an anti-impotence drug, Bayer and GSK Korea have placed an aggressive gesture against the anti-impotence drug market under the new imaginative concept of "Hard...
Concerns rising over selling of animal drugs at pharmacy
Fears are mounting that the recent selling boom of animal drugs by proprietors of pharmacy may face greater risk, industry sources said recently.
Such concerns come at a time when a number of pharmacies have engage...
Korea's finished pharmaceutical output up by 3.4% in 2003
Output of finished pharmaceuticals increased by 3.4 percent to 8.13 trillion won (totaling 15,302 items) in Korea in 2003, driven chiefly by anti-arteriosclerosis agents, antidiabetics and tranquilizers, according to ...
KGC PBM, launches micronized version of fenofibrateKorea Green Cross PBCM said it has launched in Korea Fournier's micronized version of fenofibrate, Lipidil Supra (fenofibrate) tablet, which is supplied in 160 mg. The Korean ph...
|
